VERBINDUNGEN ZUR VERSTÄRKUNG DER GLUTAMATREZEPTORWIRKUNG UND DEREN VERWENDUNG IN DER MEDIZIN

Compounds of formula (I) or a pharmaceutically acceptable salt, solvate or prodrug thereof, are disclosed: wherein R 1 is C 1-6 alkyl, haloC 1-6 alkyl, C 2-6 alkenyl, amino, monoC 1-4 alkylamino or diC 1-4 alkylamino; R 2 and R 3 , which may be the same or different, are hydrogen, halogen, C 1-6 alkyl, haloC 1-6 alkyl, C 1-4 alkoxy, haloC 1-4 alkoxy, cyano, amino, monoC 1-4 alkylamino or diC 1-4 alkylamino; each R 4 , which may be the same or different, is C 1-6 alkyl, halogen, C 1-6 alkyl, haloC 1-6 alkyl, C 1-4 alkoxy, haloC 1-4 alkoxy, cyano, nitro, amino, monoC 1-4 alkylamino or diC 1-4 alkylamino; p is 0, 1 or 2; n is 1 or 2; R 5 and R 6 , which may be the same or different, are hydrogen, halogen, C 1-6 alkyl, haloC 1-6 alkyl, C 1-4 alkoxy, haloC 1-4 alkoxy, cyano, amino, monoC 1-4 alkylamino or diC 1-4 alkylamino; and Het is thienyl, pyridyl, pyrimidinyl, pyridazinyl, pyrimidinyl, pyrazinyl, imidazolyl, pyrazolyl, pyrrolyl, quinolyl, thiazolyl or furyl, each of which may be substituted by one or more groups independently selected from the list consisting of C 1-6 alkyl, C 1-6 alkoxy, acetyl, halogen, haloC 1-6 alkyl, cyano, nitro, amino, monoC 1-4 alkylamino and diC 1-4 alkylamino. Methods of preparation of the compounds, and uses thereof in medicine, for example treatment of schizophrenia, are also disclosed.